Sjölander, Arvid

Medication for Attention Deficit–Hyperactivity Disorder and Criminality

Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine

Attention Deficit Hyperactivity DisorderPsychopathy, Forensic Psychiatry, Sexual Offending

Cited by 611

Sibling Comparison Designs: Bias From Non-Shared Confounders and Measurement Error

Frisell, T., Öberg, S., Kuja-Halkola, R., & Sjölander, A. (2012) · Epidemiology

Statistical Methods in EpidemiologyAdvanced Causal Inference Techniques

Cited by 551

Serious Transport Accidents in Adults With Attention-Deficit/Hyperactivity Disorder and the Effect of Medication: A Population-Based Study

Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 293

Paternal Age at Childbearing and Offspring Psychiatric and Academic Morbidity

D’Onofrio, B. M., Rickert, M. E., Frans, E., Kuja-Halkola, R., Almqvist, C., Sjölander, A., Larsson, H., & Lichtenstein, P. (2014) · JAMA Psychiatry

Sperm and Testicular FunctionFamily Dynamics and Relationships

Cited by 282

ADHD Medication and Substance-Related Problems

Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · American Journal of Psychiatry

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 187

First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study

Zhu, J., Fang, F., Sjölander, A., Fall, K., Adami, H. O., & Valdimarsdóttir, U. (2017) · Annals of Oncology

Cancer survivorship and careCancer, Stress, Anesthesia, and Immune Response

Cited by 168

Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes

Chang, Z., Quinn, P. D., Hur, K., Gibbons, R. D., Sjölander, A., Larsson, H., & D’Onofrio, B. M. (2017) · JAMA Psychiatry

Attention Deficit Hyperactivity DisorderTraffic and Road Safety

Cited by 166

Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder

Song, J., Sjölander, A., Joas, E., Bergen, S. E., Runeson, B., Larsson, H., Landén, M., & Lichtenstein, P. (2017) · American Journal of Psychiatry

Bipolar Disorder and TreatmentSuicide and Self-Harm Studies

Cited by 147

Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

Lagerberg, T., Fazel, S., Sjölander, A., Hellner, C., Lichtenstein, P., & Chang, Z. (2022) · Neuropsychopharmacology

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 61

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study

Tang, B., Sjölander, A., Wastesson, J. W., Maura, G., Blotiere, P.-O., Szilcz, M., Mak, J. K. L., Qin, C., Alvarsson, M., Religa, D., et al. (2024) · eClinicalMedicine

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 57

The association between Darier disease, bipolar disorder, and schizophrenia revisited: a population-based family study

Cederlöf, M., Bergen, S. E., Långström, N., Larsson, H., Boman, M., Craddock, N., Östberg, P., Lundström, S., Sjölander, A., Nordlind, K., et al. (2015) · Bipolar Disorders

Bipolar Disorder and TreatmentSchizophrenia research and treatment

Cited by 52